Upload
vuongdien
View
219
Download
0
Embed Size (px)
Citation preview
UCEIS in Practice
Date of preparation September 2013 AXHUG130882an
Simon Travis Translational Gastroenterology Unit John Radcliffe Hospital and Linacre College, University of Oxford, UK Chris A Bernhardt Bernhardt Regulatory Consulting, Ohio, USA
Discussion agenda
Background
What is the UCEIS?
Why was it developed?
How was it developed?
What does it offer?
Putting it into practice
Review of process
Making the UCEIS available
Feedback & comments re: plans/approach
Date of preparation September 2013 AXHUG130882an
Interobserver variation in histopathology
• 25 histopathologists
• Examined biopsies from 60 cases, two rounds, rectal and full colonic
series
What is the UCEIS?
UCEIS Ulcerative Colitis Endoscopic Index of Severity
Properties
Reliable (intra & inter-investigator performance)
Accounts for 88% of variance in severity
Simple (sum of 3 descriptors)
Date of preparation September 2013 AXHUG130882an
Why was it developed?
Endoscopic severity assessment important
Diagnostic tool
Clinical trial decision making – Qualification for enrollment
– Outcome assessment
Clinical treatment decision
Variability of classic methods (Baron)
Imprecise
Date of preparation September 2013 AXHUG130882an
Your evaluation of the endoscopic severity – just as you would do in your daily practice
Date of preparation September 2013 AXHUG130882an
1. Travis SPL, et al. Gut 2012;61:535–42
1. Remission
2. Mild
3. Moderate
4. Severe
Date of preparation September 2013 AXHUG130882an
1. Travis SPL, et al. Gut 2012;61:535–42
Question: Would you score this
Travis SPL, et al. Gut 2012;61:535-42. Copyright © BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.
Distribution of Baron score among specialists in the phase 1 panel as a function of the level assigned by a central reader
Date of preparation September 2013 AXHUG130882an
0
20
40
60
80
100
Ass
ign
ed
rat
ing
by
ph
ase
1 p
ane
l (%
)
0 1 2 3 Rating of central reader
(40/6) (30/5) (57/8) (29/5) n/s =
Baron 3
Baron 2
Baron 1
Baron 0
27%
53%
20%
7%
70%
16%
7%
12%
23%
37%
28%
7%
17%
76%
How do indices compare?
Date of preparation September 2013 AXHUG130882an
Endoscopic activity indices for IBD
Ulcerative colitis
1. Matts
2. Baron score
3. Modified Baron endoscopy score
4. Mayo Clinic endoscopy subscore
5. Modified Mayo Clinic endoscopy subscore
6. Sutherland UCDAI mucosal appearance
7. Powell Tuck Index
8. Blackstone Endoscopic interpretation
9. Rachmilewitz CAI index
10. Endoscopy Activity Index
11. Ulcerative Colitis Endoscopic Index of
Severity (UCEIS)
12. Ulcerative Colitis Colonoscopic Index of
Severity (UCCIS)
Crohn’s disease
1. CDEIS
2. Rutgeerts’ post-operative index
3. SES-CD
4. Absence of ulcers
So CD should be simple!
D’Haens & Sandborn et al Gastroenterology 2007;132:763-86
Palmer et al Assessing activity in UC in Lichtenstein et al Springer 2013 (in press)
Descriptions matter
Baron score Baron et al. BMJ 1964;1:89–92
Remission 0 Mild 1 Moderate 2 Severe 3 Normal: matt mucosa,
ramifying vascular
pattern clearly visible
throughout, no
spontaneous bleeding, no
bleeding to light touch
Abnormal but not
haemorrhagic:
appearances
between (0) and
(2)
Moderately
haemorrhagic: bleeding
to light touch, but no
spontaneous bleeding
seen ahead of instrument
on initial inspection
Severely
haemorrhagic:
spontaneous bleeding
seen ahead of
instrument at initial
inspection and bleeds
to light touch
Mayo Clinic Endoscopy subscore Kamm et al. Gut 2008;57:893-902
0 1 2 3
Normal Erythema, decreased
vascular pattern and
minimal granularity
Marked erythema,
friability, granularity,
absent vascular pattern,
bleeding with minimal
trauma and no ulcerations
Ulceration and
spontaneous bleeding
Baron does not describe ulceration; Mayo combines terms; neither define terms
How do indices compare?
100 patients with UC prospectively evaluated in the Oxford IBD clinic, each by four specialists, followed by videosigmoidoscopy, later scored by each specialist.
Results – Inter-observer agreement for SCCAI (k= 0.75, 95% CI 0.70-0.81)
– Mayo Clinic index (k = 0.72, 95% CI 0.67-0.78)
– Seo index (k = 0.89, 95% CI 0.83-0.95)
– Endoscopy in the Mayo Clinic index had the greatest variation (k = 0.38)
Inter-observer variation alone would have excluded up to 1 in 5 patients from recruitment or remission criteria in representative trials.
Comparing disease activity indices for ulcerative colitis. Walsh AJ et al J Crohns Colitis (2013 in press)
Date of preparation September 2013 AXHUG130882an
Development of the UCEIS
Wide inter-observer variation in endoscopic assessment – 76% agreement for ‘severe’ and 27% agreement for ‘normal’
endoscopic mucosal appearances between 10 experienced investigators and a central reader
– 30 investigators then rated 25/60 different videos for 10 descriptors and assessed overall severity on a 0-100 visual analogue scale
– Kappa statistics tested inter- and intra-observer variability for each descriptor (0.34-0.65 and 0.30-0.45 within and between observers for the 10 descriptors) Different models to predict the overall assessment of severity (visual analogue scale) used general linear mixed regression
– The final model incorporated 3 descriptors, each with precise definitions
Date of preparation September 2013 AXHUG130882an
Descriptive terms for UC
Descriptor
Vascular pattern
Bleeding
Erosions and ulcers
Extent of erosions & ulcers
Incidental friability
Mucopus
Mucosal surface
Mucosal surface
Mucosal erythema
Contact Friability Test
Transition to normal mucosa
0.00 means no agreement beyond chance, 1.00=perfect; Weighted kappa puts value on
scores from different readers being close (eg when reader 1 says 4, reader 2 says 3)
Between endoscopists:
Weighted kappa
0.42
0.37
0.45
0.42
0.40
0.40
0.34
0.34
0.35
-
-
Descriptive terms for UC
Descriptor
Vascular pattern
Bleeding
Erosions and ulcers
Extent of erosions & ulcers
Incidental friability
Mucopus
Mucosal surface
Mucosal surface
Mucosal erythema
Contact Friability Test
Transition to normal mucosa
Descriptor
(score most severe
lesions)
Likert scale
anchor points
Vascular pattern
Normal (0)
Patchy loss (1)
Obliterated (2)
Bleeding
None (0)
Mucosal (1)
Luminal mild (2)
Luminal severe (3)
Erosions and
ulcers
None (0)
Erosions (1)
Superficial ulcer (2)
Deep ulcer (3)
The three terms in combination account for 88%
of variance between observers and 96% of the
scale of the full range of severity on VAS
Travis et al Gut 2012;61:935-42
Travis et al Gastroenterology 2013 (in press)
Gut 2012; 61:535-42
Development of the UCEIS
Followed published scientific steps for scale development
Defined descriptors of severity (Phase 1)
Constructed scale (Phase 2) – Minimum number of descriptors to account for 90% of variability
Validated scale (Phase 3)
Assess symptom knowledge on UCEIS (Phase 4)
Date of preparation September 2013 AXHUG130882an
Phase 3 Correlation coefficients Partial Correlation Coefficients (adjusted for investigators) n=548
Variable Vascular
Pattern
Bleeding Erosions &
Ulcers
UCEIS
(unW)
UCEIS
Weighted
VAS
Vascular
Pattern
0.684
(<0.0001)
0.728
(<0.0001)
0.848
(<0.0001)
0.872
(<0.0001)
0.808
(<0.0001)
Bleeding 0.712
(<0.0001)
0.891
(<0.0001)
0.881
(<0.0001)
0.818
(<0.0001)
Erosions &
Ulcers
0.912
(<0.0001)
0.903
(<0.0001)
0.889
(<0.0001)
UCEIS
(unW)
0.999
(<0.0001)
0.937
(<0.0001)
UCEIS
Weighted
0.936
(<0.0001)
VAS
R2 = (0.936 squared): accounts for 88% of the variance in overall assessment of severity
between observers
Validation framework
Face validity Your expertise, Literature (1,2)
– Items ask about ‘right sort of things’
Content validity Other Scales, FA, VAS (2,3) – Items cover (all) the important aspects
Construct validity Mayo Stratum, VAS (2,3) – Sensible relationships with other variables
Internal consistency Cronbachs Alpha (3) – Items sufficiently related to each other
Reproducible Kappas, Inter-Investigator ICC (3)
– Different observers agree
Repeatable Kappas, Intra-Investigator ICC (3) – Same observer agrees on different occasions
Date of preparation September 2013 AXHUG130882an
What does it offer?
Reliable across range of severity
Known inter- and intra-investigator statistics – ICC & RR Statistics
– Kappa
Simplicity with documented process
Date of preparation September 2013 AXHUG130882an
ICC, Intraclass Correlation Coefficient; RR, relative risk
Mean assessment of overall severity as a function of its rank among all mean evaluations of severity, based on 750 evaluations performed by 30 investigators on 25 out of 60 videos
Date of preparation September 2013 AXHUG130882an
Travis SPL, et al. Gut 2012;61:535-42. Copyright © BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.
0
10
20
30
40
50
60
70
80
90
100
Rank-order based on mean severity evaluation
Me
an s
eve
rity
eva
luat
ion
0 10 20 30 40 50 60
Normal Mayo 0 Mayo 1–2 Mayo 3–5 Mayo 6–7 Mayo 8–9 Mayo 10–11 Severe
Mayo stratum
Impact of knowledge of clinical details on the mean UCEIS score
25 investigators evaluated 28 videos selected from a library of 40. There was 1 video (in the Mayo 0 stratum) for which the UCEIS score was significantly different when clinical details were supplied (p=0.021)
Date of preparation September 2013 AXHUG130882an
Travis SPL, et al. Gastroenterology 2013 (epub 24 July).
0
Rank-order based on mean UCEIS evaluation
Me
an U
CEI
S ev
alu
atio
n
1
1
2
3
4
5
6
7
8
3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39
Blinded With Sx
Reading status
Inter- and intra-investigator agreement on UCEIS and VAS (ICC, RR)
Inter-investigator
VAS ICC = 0.78
UCEIS ICC = 0.88
UCEISw ICC = 0.88
Intra-investigator
VAS ICC = 0.87
UCEIS ICC = 0.96
UCEISw ICC = 0.96
Date of preparation September 2013 AXHUG130882an
Travis SPL, et al. Gastroenterology 2013 (epub 24 July).
Inter- and intra-investigator agreement on descriptor responses
Inter-investigator ** Non-repeat evaluations
VP κ=0.54 (0.50, 0.57) M
B κ=0.48 (0.46, 0.50) M
E&U κ=0.53 (0.51, 0.57) M
Intra-investigator ** Repeat evaluations
VP κ=0.87 (0.74, 1.00) V
B κ=0.47 (0.27, 0.67) M
E&U κ=0.81 (0.67, 0.94) V
Date of preparation September 2013 AXHUG130882an
VP: Vascular Pattern; B: Mucosal bleeding; E&U: Erosions & Ulcerations Travis SPL, et al. Gastroenterology 2013 (epub 24 July).
References
Development of an ulcerative colitis endoscopic index of severity (UCEIS). Travis SPL, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lémann M, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Bernhardt CA, Mary JY, Sandborn WJ.
Gut 2012;61:535-42.
Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Travis SPL, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Schnell P, Bernhardt CA, Mary JY, Sandborn WJ.
Gastroenterology 2013 (epub 24 July)
Date of preparation September 2013 AXHUG130882an
UCEIS
Simple three descriptive terms
Vascular pattern (3-point Scale)
Bleeding (4-point Scale)
Erosions & ulcerations (4-point Scale)
Scores the most severely affected area at flexible sigmoidoscopy
Uses uniform training (exposure) to terms
Step 1: Introduces terms with examples
Step 2: Confirms understanding – Blinded evaluation of sample videos
Date of preparation September 2013 AXHUG130882an
GRADE DEFINITION PHOTO
Normal 0 Normal vascular pattern with arborisation of capillaries clearly defined
Patchy loss 1 Patchy loss or blurring of vascular pattern
Obliterated 2 Complete loss of vascular pattern
Vascular pattern reference
Date of preparation September 2013 AXHUG130882an
Images courtesy of C Bernhardt Adapted from Travis SPL, et al. Gut 2012;61:535-42
GRADE DEFINITION PHOTO
None 0 No visible blood See normal under vascular pattern
Mucosal 1 Some spots or streaks of coagulated blood on the surface of the mucosa ahead of the scope, which can be washed away
Luminal mild 2 Some free liquid blood in the lumen
Luminal severe 3 Frank blood in lumen ahead of endoscope or visible oozing from mucosa
Bleeding reference
Date of preparation September 2013 AXHUG130882an
Images courtesy of C Bernhardt Adapted from Travis SPL, et al. Gut 2012;61:535-42
GRADE DEFINITION PHOTO
None 0 Normal mucosa, no visible erosions, ulcers
See normal under vascular pattern
Erosions 1 Tiny (5 mm) defects in the mucosa, of a white or yellow colour with a flat edge
Superficial ulcer 2 Larger (>5 mm) defects in the mucosa, which are discrete fibrin-covered ulcers when compared to erosions, but remain superficial
Deep ulcer 3 Deeper excavated defects in the mucosa, with a slightly raised edge
Erosions and ulcerations reference
Date of preparation September 2013 AXHUG130882an
Images courtesy of C Bernhardt
Sco
re m
ost
se
vere
lesi
on
s
Adapted from Travis SPL, et al. Gut 2012;61:535-42
UCEIS© 2013
Descriptor (score most severe lesions)
Likert scale anchor points
Definition
Vascular pattern
Normal (0) Normal vascular pattern with arborisation of capillaries clearly defined, or with blurring or patchy loss of capillary margins
Patchy loss (1) Patchy obliteration of vascular pattern
Obliterated (2) Complete obliteration of vascular pattern
Bleeding
None (0) No visible blood
Mucosal (1) Some spots or streaks of coagulated blood on the surface of the mucosa ahead of the scope, which can be washed away
Luminal mild (2) Some free liquid blood in the lumen
Luminal severe (3) Frank blood in the lumen ahead of endoscope or visible oozing from mucosa after washing intra-luminal blood, or visible oozing from a haemorrhagic mucosa
Erosions and ulcers
None (0) Normal mucosa, no visible erosions or ulcers
Erosions (1) Tiny (<5mm) defects in the mucosa, of a white or yellow colour with a flat edge
Superficial ulcer (2) Larger (>5mm) defects in the mucosa, which are discrete fibrin-covered ulcers when compared to erosions, but remain superficial
Deep ulcer (3) Deeper excavated defects in the mucosa, with a slightly raised edge
Score the worst affected area at sigmoidoscopy, especially on insertion Date of preparation September 2013 AXHUG130882an Travis SPL, et al. Gastroenterology 2013 (in press).
Putting the UCEIS into practice
2 steps needed
Training
Review of definitions and examples (9 video clips)
Verification of understanding (qualification)
Rate 4 standardized videos (Stage 2 agreement)
Qualification criteria – VP and bleeding – within 1 unit of Stage 2 mean – E&U – match Stage 2 mean
Re-qualify if needed – Evaluate 3 videos of ‘missed term’
Score the worst affected area
Evaluate on insertion (esp. bleeding)
Date of preparation September 2013 AXHUG130882an
Training example: UCEIS = 0 (normal)
Date of preparation September 2013 AXHUG130882an
VP training example
Date of preparation September 2013 AXHUG130882an
Images courtesy of S Travis
E&U training example
Date of preparation September 2013 AXHUG130882an
Images courtesy of S Travis
Importance of 2 steps
Design confirmed understanding of terms
Stage 3 and 4
UCEIS characteristics reflect design
About 50% qualified on 1st attempt
About 45% qualified on 2nd attempt
About 5% did not participate
Date of preparation September 2013 AXHUG130882an
Qualification example
Date of preparation September 2013 AXHUG130882an
Images courtesy of S Travis
Question: Score this
Total score (most
severe area)
0
1
2
3
4
5
6
7
8
Date of preparation September 2013 AXHUG130882an
Descriptor (score most severe lesions)
Likert scale anchor points
Definition
Vascular pattern
Normal (0) Normal vascular pattern with arborisation of capillaries clearly defined, or with blurring or patchy loss of capillary margins
Patchy loss (1) Patchy obliteration of vascular pattern
Obliterated (2) Complete obliteration of vascular pattern
Bleeding
None (0) No visible blood
Mucosal (1) Some spots or streaks of coagulated blood on the surface of the mucosa ahead of the scope, which can be washed away
Luminal mild (2) Some free liquid blood in the lumen
Luminal severe (3) Frank blood in the lumen ahead of endoscope or visible oozing from mucosa after washing intra-luminal blood, or visible oozing from a haemorrhagic mucosa
Erosions and ulcers
None (0) Normal mucosa, no visible erosions or ulcers
Erosions (1) Tiny (<5mm) defects in the mucosa, of a white or yellow colour with a flat edge
Superficial ulcer (2) Larger (>5mm) defects in the mucosa, which are discrete fibrin-covered ulcers when compared to erosions, but remain superficial
Deep ulcer (3) Deeper excavated defects in the mucosa, with a slightly raised edge
Making UCEIS available
Target user groups
Clinical trial users
– Central readers
– Investigators
Clinical practice
– Group practice
– Individual
Endoscopy trainees
Validate in Asia
‘Copyright’
Refers only to the wording of the descriptive terms
Date of preparation September 2013 AXHUG130882an
Vision
Make UCEIS readily available for broad use
Internet access for professionals – Europe
– Asia
–North America
– South America
No cost to user
Publication acknowledges copyright of UCEIS – “© 2013 Warner Chilcott. All Rights Reserved. The UCEIS Index
was developed by the UCEIS Study Group”
Date of preparation September 2013 AXHUG130882an
Concluding remarks
Steering Committee
Co-Chairs: Drs. Travis and Sandborn
Members: Drs. Dan Schnell, Piotr Krzeski, Maria Abreu, Doug Altman, Jean-Frédéric Colombel, Brian G Feagan, Stephen B Hanauer, Gary R Lichtenstein, Philippe Marteau, Walter Reinisch, Bruce E Sands, Bruce R Yacyshyn, Jean-Yves Mary, and Chris Bernhardt
Date of preparation September 2013 AXHUG130882an